Skip to main content

CORRECTION article

Front. Immunol., 08 August 2024
Sec. Viral Immunology

Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis

Sara Garcinuo,&#x;Sara Garcinuño1,2†Antonio Lalueza,,,&#x;Antonio Lalueza1,3,4,5†Francisco Javier Gil-Etayo,Francisco Javier Gil-Etayo1,2Raquel Diaz-Simn,Raquel Diaz-Simón1,3Ignacio Lizasoain,Ignacio Lizasoain1,4Ana Moraga,Ana Moraga1,6Blanca Diaz-BenitoBlanca Diaz-Benito1Laura Naranjo,Laura Naranjo1,2Oscar Cabrera-Marante,Oscar Cabrera-Marante1,2Daniel Enrique Pleguezuelo,Daniel Enrique Pleguezuelo1,2Maria Ruiz-Ruigomez,Maria Ruiz-Ruigomez1,3Blanca AyusoBlanca Ayuso3Estibaliz ArrietaEstibaliz Arrieta3Dolores Folgueira,,Dolores Folgueira1,4,7Estela Paz-Artal,,Estela Paz-Artal1,2,4Cecilia CuetoCecilia Cueto8Carlos Lumbreras,,,Carlos Lumbreras1,3,4,5Antonio Serrano,,*Antonio Serrano1,2,9*Manuel Serrano,Manuel Serrano1,2
  • 1Healthcare Research Institute Hospital 12 de Octubre (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain
  • 2Immunology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
  • 3Internal Medicine Department, Hospital Universitario 12 de Octubre, Madrid, Spain
  • 4Faculty of Medicine, Universidad Complutense, Madrid, Spain
  • 5Red de Infecciones en Inmunodeprimidos no VIH e infecciones relacionadas con la asistencia sanitaria (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
  • 6Cell Biology Department, Faculty of Medicine, Universidad Complutense, Madrid, Spain
  • 7Microbiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
  • 8Biochemistry Department, Hospital Universitario 12 de Octubre, Madrid, Spain
  • 9Red de Centros de Investigación Biomédica en Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain

A Corrigendum on
Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis

By Garcinuño S, Lalueza A, Gil-Etayo FJ, Dıaz-Simon R, Lizasoain I, Moraga A, Diaz-Benito B, Naranjo L, Cabrera-Marante O, Pleguezuelo DE, Ruiz-Ruigomez M, Ayuso B, Arrieta E, Folgueira D, Paz-Artal E, Cueto C, Lumbreras C, Serrano A and Serrano M (2024). Front. Immunol. 15:1443096. doi: 10.3389/fimmu.2024.1443096

In the published article, there was an error in the Funding statement. Incorrect funding bodies and project numbers were listed. The correct Funding statement appears below.

“The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study has been funded by Instituto de Salud Carlos III (ISCIII) (Spanish Ministry of Economy and Competitiveness) through the project “PI20/01361” and the project “PI17/01129” and co-funded by the European Union. And by a grant from Fundación Mutua Madrileña (P177122021).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: influenza, flu, apolipoprotein H, ApoH, β2GPI, IL15, IL8, early immune response

Citation: Garcinuño S, Lalueza A, Gil-Etayo FJ, Diaz-Simón R, Lizasoain I, Moraga A, Diaz-Benito B, Naranjo L, Cabrera-Marante O, Pleguezuelo DE, Ruiz-Ruigomez M, Ayuso B, Arrieta E, Folgueira D, Paz-Artal E, Cueto C, Lumbreras C, Serrano A and Serrano M (2024) Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis. Front. Immunol. 15:1472919. doi: 10.3389/fimmu.2024.1472919

Received: 30 July 2024; Accepted: 31 July 2024;
Published: 08 August 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Garcinuño, Lalueza, Gil-Etayo, Diaz-Simón, Lizasoain, Moraga, Diaz-Benito, Naranjo, Cabrera-Marante, Pleguezuelo, Ruiz-Ruigomez, Ayuso, Arrieta, Folgueira, Paz-Artal, Cueto, Lumbreras, Serrano and Serrano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Antonio Serrano, autoimmunity.imas12@h12o.es

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.